Cardiology News and Research

Latest Cardiology News and Research

Condition causing obstruction of arteries important in high blood pressure diagnosis and treatment

An under-recognized and usually asymptomatic condition called subclavian artery stenosis – an obstruction of arteries located under the clavicle, or collarbone – is important in the diagnosis and treatment of high blood pressure

30 Aug 2004

Kiwis reverse heart disease in diabetics

New Zealand biopharmaceutical company Protemix Corporation has announced the discovery of a treatment which appears to reverse heart disease in people suffering from diabetes and may lead to a more effective intervention in a major cause of death worldwide.

30 Aug 2004

Surgery for angina in the elderly provides long-term mortality

Elderly people who undergo surgery or angioplasty to treat chest pain fare just as well long-term as those treated with medication, researchers report in Circulation: Journal of the American Heart Association.

30 Aug 2004

Diabetes mellitus in acute coronary syndromes – worse for women

Diabetes is associated with worse prognosis in patients with myocardial infarction, but if there is a difference between men and women in this respect is less well known.

30 Aug 2004

Summary of The Euro Heart Survey on the diabetic state of patients with coronary artery disease

The survey engaged 110 centres in 25 countries recruiting 4,196 patients referred to a cardiology department or outpatient clinic due to CAD. A total of 2 107 of these patients were admitted on acute basis while 2,854 had an elective consultation. Patient data were collected via a web-based case record form.

30 Aug 2004

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

An enzyme found in nearly all animal and human cells acts as a natural brake to prevent potentially deadly runaway inflammation, UCSF scientists have discovered.

30 Aug 2004

Study suggests intramyocardial injection of cells from bone marrow might be an alternative for heart transplantation

Cardiovascular disease remains the leading cause of morbidity and mortality around the world and patients with end-stage ischemic heart failure carry the highest morbid-mortality rate.

30 Aug 2004

Converting cells into heart muscle

This plasticity concept – the ability of bone marrow cell to transdifferentiate into heart muscle cell – is supported by experimental and clinical data. Another possibility is to replace the missing function by causing transdifferentiation of existing cells. Transdifferentiation means converting one sort of cell, e.g. fibroblast, into another, e.g. muscle cell.

30 Aug 2004

Early use of aggressive statin therapy may offer some benefit for coronary patients

Statins initiated early after a patient experiences an acute coronary syndrome (ACS) event at dosages above the typical starting dose may help reduce subsequent cardiovascular events, but the high dose regimen used may increase the risk for muscle-related complications, according to the results from the Phase Z portion of the A to Z Trial released on the JAMA website today.

30 Aug 2004

High blood pressure combined with elevated LDL cholesterol more than triples risk of heart attack

High blood pressure and high LDL-cholesterol add up to more than just double trouble for heart health, a Penn State College of Medicine study reports.

30 Aug 2004

The proper use of drugs to treat heart disease reduces the need for hospital interventions

Regular attacks of chest pain induced by exercise (angina pectoris) is a common condition caused by blockages of the blood vessels that supply the heart (coronary heart disease).

29 Aug 2004

Vast majority of heart attacks may be predicted by nine easily measurable factors

A major Canadian-led global study has found that the vast majority of heart attacks may be predicted by nine easily measurable factors and that these factors are the same in virtually every region and ethnic group worldwide.

29 Aug 2004

New study confirms benefits of rimonabant in weight loss

Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight

29 Aug 2004

Dronedarone is effective and well-tolerated in the prevention of atrial fibrillation

New anti-arrhythmic agent, dronedarone, is highly effective in the prevention of atrial fibrillation or atrial flutter recurrence, serious disorders of cardiac rhythm, and is well-tolerated by patients.

29 Aug 2004

Atrial fibrillation patients often receive needless treatment

Results of the Euro Heart Survey on atrial fibrillation (AF), demonstrate that many AF patients receive clot-preventing drugs while not at risk for stroke.

29 Aug 2004

U.S. FDA study shows Canadian drugs to be more expensive

If you think all drugs from Canada are cheaper than U.S. drugs, think again. In the United States, generic drugs - roughly half of all prescriptions - are often cheaper than both Canadian brand-name drugs and Canadian generic drugs, according to a study by the Food and Drug Administration.

29 Aug 2004

Tomato juice may help type 2 diabetics

Tomato juice may be the key to decreasing hyperactive platelet aggregation, which can lead to heart disease, according to the latest nutrition and dietetics study by HMRI researchers based at the University of Newcastle.

27 Aug 2004

Two new findings in the field of primary prevention for dementia and Alzheimer’s disease

The first is that both high and low blood pressure increase the chances of developing dementia. The second is that an active and socially integrated lifestyle protects against dementia.

27 Aug 2004

Ephedra substitute - Seville orange may have risks

People taking “ephedra-free” weight loss products that contain the herb Citrus aurantium, or Seville orange, may be doing more harm to their body than good, according to a new review published by Georgetown University Medical Center researchers.

27 Aug 2004

Statins (HMG-CoA reductase inhibitors), are effective long term

Statins (HMG-CoA reductase inhibitors), a class of drugs that block production of cholesterol in the liver, lower total cholesterol and LDL and are also associated with cardiovascular benefits, are effective in the long term, conclude authors of a study in this week’s issue of THE LANCET.

26 Aug 2004

Cardiology News and Research

Latest Cardiology News and Research

Condition causing obstruction of arteries important in high blood pressure diagnosis and treatment

Kiwis reverse heart disease in diabetics

Surgery for angina in the elderly provides long-term mortality

Diabetes mellitus in acute coronary syndromes – worse for women

Summary of The Euro Heart Survey on the diabetic state of patients with coronary artery disease

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

Study suggests intramyocardial injection of cells from bone marrow might be an alternative for heart transplantation

Converting cells into heart muscle

Early use of aggressive statin therapy may offer some benefit for coronary patients

High blood pressure combined with elevated LDL cholesterol more than triples risk of heart attack

The proper use of drugs to treat heart disease reduces the need for hospital interventions

Vast majority of heart attacks may be predicted by nine easily measurable factors

New study confirms benefits of rimonabant in weight loss

Dronedarone is effective and well-tolerated in the prevention of atrial fibrillation

Atrial fibrillation patients often receive needless treatment

U.S. FDA study shows Canadian drugs to be more expensive

Tomato juice may help type 2 diabetics

Two new findings in the field of primary prevention for dementia and Alzheimer’s disease

Ephedra substitute - Seville orange may have risks

Statins (HMG-CoA reductase inhibitors), are effective long term

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cardiology News and Research

Latest Cardiology News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in